ANG Lifesciences India Hits 52-Week Low Amidst Strong Sell Call from MarketsMOJO
ANG Lifesciences India, a microcap pharmaceutical company, has hit a 52-week low on November 19, 2024, with a Strong Sell call from MarketsMojo. The stock price has declined by -1.28% today and is trading below its moving averages. The company has seen a negative 1-year performance of -32.54%, indicating tough competition in the pharmaceutical industry. Investors should closely monitor the company's performance and market conditions before making any investment decisions.
ANG Lifesciences India, a microcap pharmaceutical company, has recently hit a 52-week low on November 19, 2024. This news has been accompanied by a "Strong Sell" call from MarketsMOJO, a leading financial analysis platform.
The stock price of ANG Lifesciences India has reached a low of Rs. 43.5, underperforming the sector by -1.28% today. This marks the second consecutive day of losses for the company, with a decline of -0.56% in this period. The stock is also currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In comparison to the Sensex performance of 18.74%, ANG Lifesciences India has seen a negative 1-year performance of -32.54%. This indicates a significant decline in the company's stock value over the past year.
While there has been no mention of future potential or investor interest, it is important to note that ANG Lifesciences India operates in the highly competitive pharmaceutical and drugs industry. As a microcap company, it may face challenges in competing with larger players in the market.
Investors and stakeholders should closely monitor the performance of ANG Lifesciences India and consider the current market conditions before making any investment decisions. This news is for informational purposes only and does not constitute a recommendation to buy or sell the stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
